We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Researchers have used a CRISPR-modified bacterium for the first time to replace daily injections in short bowel syndrome. Reduce dependence on IV drips. Read the breakthrough analysis.
